MXCT
MaxCyte Inc
NASDAQ: MXCT · HEALTHCARE · MEDICAL DEVICES
$0.84
-3.24% today
Updated 2026-05-08
Market cap
$90.34M
P/E ratio
—
P/S ratio
2.74x
EPS (TTM)
$-0.42
Dividend yield
—
52W range
$1 – $2
Volume
0.9M
MaxCyte Inc (MXCT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+6.1%
Last 4 quarters
Revenue YoY growth
-16.0%
Most recent quarter
EPS YoY growth
+43.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-6.2%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-9.9%
2026-03-17
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-17 | $-0.06 | +27.4% | $0.81 | $0.73 | -9.9% |
| 2025-11-12 | $-0.12 | -5.9% | $1.55 | $1.51 | -2.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.08 | $-0.06 | +27.4% | $7.30M | -16.0% |
| 2025-09-30 | $-0.11 | $-0.12 | -5.9% | $6.83M | -16.4% |
| 2025-06-30 | $-0.10 | $-0.12 | -20.0% | $8.51M | -18.4% |
| 2025-03-31 | $-0.13 | $-0.10 | +23.1% | $10.39M | -8.4% |
| 2024-12-31 | $-0.12 | $-0.10 | +16.7% | $8.69M | -44.5% |
| 2024-09-30 | $-0.12 | $-0.11 | +8.3% | $8.16M | +2.0% |
| 2024-06-30 | $-0.13 | $-0.09 | +30.8% | $10.43M | +15.3% |
| 2024-03-31 | $-0.13 | $-0.09 | +30.8% | $11.34M | +32.3% |
| 2023-12-31 | $-0.07 | $-0.05 | +28.6% | $15.66M | — |
| 2023-09-30 | $-0.10 | $-0.11 | -10.0% | $8.00M | — |
| 2023-06-30 | $-0.10 | $-0.10 | +0.0% | $9.04M | — |
| 2023-03-31 | $-0.11 | $-0.11 | +0.0% | $8.58M | — |
Frequently asked questions
Has MaxCyte Inc beaten earnings estimates?
MaxCyte Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +6.1% over the last 4 quarters.
How does MXCT stock react to earnings?
MXCT stock has moved an average of -6.2% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is MaxCyte Inc's revenue growth rate?
MaxCyte Inc reported year-over-year revenue growth of -16.0% in its most recent quarter, with EPS growing +43.4% year-over-year.